Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPIAC: Contrast Injection Protocols in Cerebral Angiography for Unruptured Intracranial Aneurysms
2025-524884-18-01Phase 3Authorised
- Sponsor
- Strasbourg University Hospital
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of iodixanol in brain aneurysm (IA) (4 arms), sponsored by Strasbourg University Hospital. Primary endpoint: Primary: Ratio of exploitable 2D and 3D images per protocol. Planned start May 2026; status: authorised.
02
Drugs
iodixanol
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on 2025-524884-18-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524884-18-01.